178 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
SCIENTIFIC PROGRAMME
170
S-230
Symposium
08:15–09:45
|
Room M2 /M3
TOPIC 5:
Neurotic, stress-related and somatoform
disorders
Health care of OCD from the patient and profes-
sional perspective: progress and challenges for the
future
Chairs:
Antonia Peters, Germany
Michael Zaudig, Germany
001
The prevalence of OCD and OCD spectrum
disorders
Michael Zaudig, Germany
002
OCD from the patient's perspective
Oliver Sechting, Germany
003
Intensive outpatient exposure in the treatment
of OCD
Thomas Hillebrand, Germany
004
Intensive inpatient treatment of severe OCD:
short- and long-term efficacy
Ulrich Voderholzer, Germany
S-231
Symposium
08:15–09:45
|
Room M4 /M5
TOPIC 23:
Health care research and models, health care
policy
Arts therapies – an international overview
›
DGPPN Section: Health Care Professions
›
DGPPN Section: Psychosocial Care Research
Chairs:
Kathrin Seifert, Germany
Thomas Becker, Germany
001
Art therapy and mental illness – a health
promotion perspective
Patricia Fenner, Australia
002
Rawda Said Abdelazim, Egypt
003
Dance movement therapy research findings and
perspectives in Germany, Switzerland and Egypt
Iris Bräuninger, Switzerland
Rawda Said Abdelazim
004
An update on music therapy research in psychiatry
Gitta Strehlow, Germany
005
The arts therapies in the treatment of depression:
what evidence do we have?
Vicky Karkou, United Kingdom
Ania Zubala
S-232
Symposium
08:15–09:45
|
Room M1
TOPIC 25:
Training and continuing education
How psychoanalysis can contribute to psychiatric
education
›
WPA Section: Psychoanalysis in Psychiatry
›
ZONE 6: Western Europe
Chairs:
Michel Botbol, France
Graciela Beatriz Onofrio, Argentina
001
Contribution of psychoanalysis to pharmaco-
therapy education and training
Allan Tasman, USA
002
How psychiatric education should care about
psychiatrists' mental health
Aldo Suarez, Mexico
003
Programs on medical education for psychiatrists:
the psychopathology of everyday life nowadays
Graciela Beatriz Onofrio, Argentina
004
Education and training in psychotherapy for
personality disorders
Dusica Lecic-Tosevski, Serbia
S-233
Symposium
08:15–09:45
|
Room Weimar 3
TOPIC 3:
Psychotic disorders
Novel approaches to managing obesity and metabolic
disturbances in anti-psychotics-treated patients
Chairs:
Margaret Hahn, Canada
Bjorn Ebdrup, Denmark
001
Treatment of clozapine-associated obesity and
diabetes with exenatide (CODEX) in adults with
schizophrenia: a pilot randomised controlled trial
Dan Siskind, Australia
002
Treatment of antipsychotic-associated obesity
with a GLP-1 receptor agonist: results from an
investigator-initiated prospective, randomized, pla-
cebo-controlled, double-blinded intervention study
(The TAO study)
Bjorn Ebdrup, Denmark
003
Does a GLP-1 receptor agonist change glucose
tolerance in patients treated with antipsychotic
medications? A randomised, double-blinded, place-
bo-controlled clinical trial
Anders Fink-Jensen, Denmark